Results 21 to 30 of about 1,479,964 (315)
Aldosterone and Cardiovascular Disease [PDF]
Current Problems in Cardiology, 2009 Aldosterone is an adrenal hormone that regulates sodium, fluid, and potassium balance. Jerome Conn first described the syndrome of autonomous and excessive aldosterone secretion or "primary aldosteronism." Contrary to the historical belief, recent studies indicate that primary aldosteronism is a common cause of hypertension with a prevalence of 5-10 ...
Gaddam, Krishna K. +3 more
openaire +5 more sources
Long‐Term Survival of Patients With Left Ventricular Noncompaction
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021 Background The prognosis of left ventricular noncompaction (LVNC) remains elusive despite its recognition as a clinical entity for >30 years. We sought to identify clinical and imaging characteristics and risk factors for mortality in patients with LVNC.
Vaibhav R. Vaidya +13 more
doaj +1 more source
Testosterone and Cardiovascular Disease [PDF]
The Open Cardiovascular Medicine Journal, 2016 Cardiovascular disease [CVD] is a leading cause of mortality accounting for a global incidence of over 31%. Atherosclerosis is the primary pathophysiology underpinning most types of CVD. Historically, modifiable and non-modifiable risk factors were suggested to precipitate CVD.
Tambo, Amos +2 more
openaire +3 more sources
Tetrahydrobiopterin and Cardiovascular Disease [PDF]
Arteriosclerosis, Thrombosis, and Vascular Biology, 2006 Tetrahydrobiopterin (BH 4 ) is an essential cofactor for the aromatic amino acid hydroxylases, which are essential in the formation of neurotransmitters, and for nitric oxide synthase. It is presently used clinically to treat some forms of phenylketonuria (PKU) that can be ameliorated by BH 4
Moens, An L., Kass, David A.
openaire +3 more sources
State-of-the-art technology for cardiovascular research
, 2021 Heart and vascular diseases are responsible for tens of millions of deaths annually, underscoring an urgent need to improve the existing clinical practice in order to benefit patients.
А. E. Yuzhalin, A. E. Yuzhalin
core +1 more source
Indian Heart Journal, 2021 Background: Percutaneous transvenous mitral commissurotomy (PTMC) is the standard of treatment for symptomatic severe rheumatic mitral stenosis (MS).
Abdul Momen +10 more
doaj +1 more source
Exercise and cardiovascular diseases [PDF]
Acta Physiologica, 2014 Exercise is a physiologic stressor that has multiple beneficial effects on cardiovascular system. Currently exercise training is a class I intervention as part of a multifactorial long-term process that includes: clinical assistance, assessment of global cardiovascular risk, identification of specific objective for each cardiovascular risk factor ...
Philipp Hillmeister +4 more
openaire +6 more sources
Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023 [PDF]
Background: Cardiovascular diseases (CVDs) are the leading cause of mortality and are among the foremost causes of disability globally. CVD burden has continued to increase in most countries since 1990, with trends driven by changing exposures to harmful
Mario D'Oria +4 more
core +3 more sources
Experience in the development of a system for repeated prosthetic heart valves
Сибирский научный медицинский журнал, 2023 The failure of heart valve bioprostheses, requiring repeated intervention to replace them, is a serious drawback that narrows the scope of such devices.
E. A. Ovcharenko +12 more
doaj +1 more source
Results of preclinical trials in a sheep model of biodegradable small-diameter vascular grafts
Вестник трансплантологии и искусственных органов, 2022 Surface modification of polymer vascular matrices is a promising development for preventing vascular graft thrombosis, improving long-term patency and accelerating remodeling. Objective: to study the outcomes of long-term patency of PHBV/PCL/GFmix grafts
L. V. Antonova +11 more
doaj +1 more source